Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tove Agner

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
Contact Dermatitis|November 22, 2023
Demographics, characteristics and medical treatment among adults with hand eczema in Denmark. A cross-sectional validation and registry-based studyMaria Oberländer Christensen, Yasemin Topal Yüksel, Ida Vittrup, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|January 12, 2022
Mild to moderate atopic dermatitis severity can be reliably assessed using smartphone-photographs taken by the patient at home: A validation studyZarqa Ali, Andrei Chiriac, Theis Bjerre-Christensen, et al.
Journal of the American Academy of Dermatology|March 13, 2025
Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic Hand Eczema: Results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trialsMelinda Gooderham, Sonja Molin, Robert Bissonnette, et al.
The Journal of Dermatological Treatment|January 19, 2021
Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational studyMarjolein de Bruin-Weller, Andrew E Pink, Annalisa Patrizi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 6, 2023
A nationwide 104 weeks real-world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head-and-neck dermatitisIda Vittrup, Niels Steen Krogh, Henrik Hedegaard Pliess Larsen, et al.
Acta Dermato-Venereologica|September 14, 2020
Management of Ocular Manifestations of Atopic Dermatitis: A Consensus Meeting Using a Modified Delphi ProcessJacob P Thyssen, Steffen Heegaard, Lena Ivert, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 25, 2023
Which outcomes should be measured in hand eczema trials? Results from patient interviews and an expert surveyHenriette Rönsch, Frederike Schiffers, Robert Ofenloch, et al.
Contact Dermatitis|May 13, 2017
Current knowledge on biomarkers for contact sensitization and allergic contact dermatitisSjors A Koppes, Kristiane A Engebretsen, Tove Agner, et al.
Contact Dermatitis|July 17, 2015
European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practiceJeanne D Johansen, Kristiina Aalto-Korte, Tove Agner, et al.
Contact Dermatitis|June 21, 2026
European Society of Contact Dermatitis Guideline for Diagnostic Patch Testing-Recommendations on Best Practice (Update 2026)Wolfgang Uter, Olivier Aerts, Tove Agner, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Contact Dermatitis|November 22, 2023
Demographics, characteristics and medical treatment among adults with hand eczema in Denmark. A cross-sectional validation and registry-based studyMaria Oberländer Christensen, Yasemin Topal Yüksel, Ida Vittrup, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|January 12, 2022
Mild to moderate atopic dermatitis severity can be reliably assessed using smartphone-photographs taken by the patient at home: A validation studyZarqa Ali, Andrei Chiriac, Theis Bjerre-Christensen, et al.
Journal of the American Academy of Dermatology|March 13, 2025
Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic Hand Eczema: Results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trialsMelinda Gooderham, Sonja Molin, Robert Bissonnette, et al.
The Journal of Dermatological Treatment|January 19, 2021
Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational studyMarjolein de Bruin-Weller, Andrew E Pink, Annalisa Patrizi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 6, 2023
A nationwide 104 weeks real-world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head-and-neck dermatitisIda Vittrup, Niels Steen Krogh, Henrik Hedegaard Pliess Larsen, et al.
Acta Dermato-Venereologica|September 14, 2020
Management of Ocular Manifestations of Atopic Dermatitis: A Consensus Meeting Using a Modified Delphi ProcessJacob P Thyssen, Steffen Heegaard, Lena Ivert, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 25, 2023
Which outcomes should be measured in hand eczema trials? Results from patient interviews and an expert surveyHenriette Rönsch, Frederike Schiffers, Robert Ofenloch, et al.
Contact Dermatitis|May 13, 2017
Current knowledge on biomarkers for contact sensitization and allergic contact dermatitisSjors A Koppes, Kristiane A Engebretsen, Tove Agner, et al.
Contact Dermatitis|July 17, 2015
European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practiceJeanne D Johansen, Kristiina Aalto-Korte, Tove Agner, et al.
Contact Dermatitis|June 21, 2026
European Society of Contact Dermatitis Guideline for Diagnostic Patch Testing-Recommendations on Best Practice (Update 2026)Wolfgang Uter, Olivier Aerts, Tove Agner, et al.
Pageof 18